| 1 | SASP-Mediated Complement Cascade Amplification h-58e4635a | C1Q/C3 | validated | 0.822 | 2026-05-16 | Open → |
| 2 | Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs) h-11795af0 | APOE | promoted | 0.795 | 2026-05-13 | Open → |
| 3 | Senescent Microglia Resolution via Maresins-Senolytics Combination h-3f02f222 | BCL2L1 | debated | 0.791 | 2026-05-16 | Open → |
| 4 | Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation h-23a3cc07 | FCGRT | promoted | 0.773 | 2026-05-16 | Open → |
| 5 | APOE4 Allosteric Rescue via Small Molecule Chaperones h-44195347 | APOE | debated | 0.765 | 2026-05-13 | Open → |
| 6 | SASP-Mediated Cholinergic Synapse Disruption h-1acdd55e | MMP2/MMP9 | promoted | 0.763 | 2026-05-13 | Open → |
| 7 | Multi-Modal Stress Response Harmonization h-1e564178 | NR3C1/CRH/TNFA | promoted | 0.756 | 2026-05-13 | Open → |
| 8 | Circadian-Synchronized Proteostasis Enhancement h-0e0cc0c1 | CLOCK/ULK1 | promoted | 0.744 | 2026-05-13 | Open → |
| 9 | Smartphone-Detected Motor Variability Correction h-072b2f5d | DRD2/SNCA | promoted | 0.742 | 2026-05-13 | Open → |
| 10 | Senescent Cell Mitochondrial DNA Release h-1a34778f | CGAS/STING1/DNASE2 | debated | 0.742 | 2026-05-16 | Open → |
| 11 | PARP1 Inhibition Therapy h-69919c49 | PARP1 | promoted | 0.738 | 2026-05-13 | Open → |
| 12 | Senescence-Induced Lipid Peroxidation Spreading h-7957bb2a | GPX4/SLC7A11 | debated | 0.730 | 2026-05-13 | Open → |
| 13 | Circadian Rhythm Entrainment of Reactive Astrocytes h-5706bbd7 | BMAL1 | debated | 0.722 | 2026-05-13 | Open → |
| 14 | Retinal Vascular Microcirculation Rescue h-35f04e1b | PDGFRB/ANGPT1 | debated | 0.718 | 2026-05-13 | Open → |
| 15 | Purinergic Signaling Polarization Control h-0758b337 | P2RY1 and P2RX7 | debated | 0.713 | 2026-05-13 | Open → |
| 16 | Metabolic Circuit Breaker via Lipid Droplet Modulation h-3d993b5d | PLIN2 | debated | 0.709 | 2026-05-13 | Open → |
| 17 | Autophagosome Maturation Checkpoint Control h-5e68b4ad | STX17 | debated | 0.709 | 2026-05-13 | Open → |
| 18 | Microglial Efferocytosis Enhancement via GPR32 Superagonists h-470ff83e | CMKLR1 | debated | 0.704 | 2026-05-16 | Open → |
| 19 | Microglial Purinergic Reprogramming h-5daecb6e | P2RY12 | debated | 0.701 | 2026-05-16 | Open → |
| 20 | Perforant Path Presynaptic Terminal Protection Strategy h-76888762 | PPARGC1A | debated | 0.696 | 2026-05-16 | Open → |
| 21 | Complement C1q Mimetic Decoy Therapy h-1fe4ba9b | C1QA | debated | 0.695 | 2026-05-13 | Open → |
| 22 | Ocular Immune Privilege Extension h-6a065252 | FOXP3/TGFB1 | debated | 0.692 | 2026-05-13 | Open → |
| 23 | Extracellular Matrix Stiffness Modulation h-725c62e9 | PIEZO1 | debated | 0.691 | 2026-05-13 | Open → |
| 24 | TREM2 Conformational Stabilizers for Synaptic Discrimination h-044ee057 | TREM2 | debated | 0.685 | 2026-05-13 | Open → |
| 25 | Pericyte Contractility Reset via Selective PDGFR-β Agonism h-73e4340b | PDGFRB | debated | 0.684 | 2026-05-13 | Open → |
| 26 | Chaperone-Mediated APOE4 Refolding Enhancement h-637a53c9 | HSPA1A, HSP90AA1, DNAJB1, FKBP5 | debated | 0.680 | 2026-05-13 | Open → |
| 27 | Osmotic Gradient Restoration via Selective AQP1 Enhancement in Choroid Plexus h-0dea0ed5 | AQP1 | debated | 0.680 | 2026-05-13 | Open → |
| 28 | Metabolic Reprogramming via Microglial Glycolysis Inhibition h-38292315 | HK2 | debated | 0.672 | 2026-05-13 | Open → |
| 29 | Mitochondrial-Lysosomal Contact Site Engineering h-0791836f | RAB7A | debated | 0.668 | 2026-05-13 | Open → |
| 30 | Complement C1q Subtype Switching h-5a55aabc | C1QA | debated | 0.665 | 2026-05-16 | Open → |
| 31 | Biorhythmic Interference via Controlled Sleep Oscillations h-49791706 | GABRA1 | debated | 0.661 | 2026-05-13 | Open → |
| 32 | Mitochondrial RNA Granule Rescue Pathway h-1e2bd420 | SYNCRIP | debated | 0.656 | 2026-05-13 | Open → |
| 33 | Optogenetic Microglial Deactivation via Engineered Inhibitory Opsins h-782b40b1 | CX3CR1 | debated | 0.655 | 2026-05-13 | Open → |
| 34 | Arginine Methylation Enhancement Therapy h-19003961 | PRMT1 | debated | 0.653 | 2026-05-13 | Open → |
| 35 | Mitochondrial SPM Synthesis Platform Engineering h-13bbfdc5 | ALOX5 | debated | 0.647 | 2026-05-13 | Open → |
| 36 | Grid Cell-Specific Metabolic Reprogramming via IDH2 Enhancement h-57862f8a | IDH2 | debated | 0.646 | 2026-05-13 | Open → |
| 37 | Quantum Coherence Disruption in Cellular Communication h-4a31c1e0 | TUBB3 | debated | 0.627 | 2026-05-16 | Open → |
| 38 | Heat Shock Protein 70 Disaggregase Amplification h-5dbfd3aa | HSPA1A | debated | 0.625 | 2026-05-13 | Open → |
| 39 | Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics h-513a633f | ANXA1 | debated | 0.625 | 2026-05-16 | Open → |
| 40 | Sphingolipid Metabolism Reprogramming h-6657f7cd | CERS2 | debated | 0.620 | 2026-05-16 | Open → |
| 41 | Low Complexity Domain Cross-Linking Inhibition h-69d383ea | TGM2 | debated | 0.617 | 2026-05-13 | Open → |
| 42 | Netrin-1 Gradient Restoration h-05b8894a | NTN1 | debated | 0.595 | 2026-05-13 | Open → |
| 43 | Astroglial Gap Junction Coordination via Connexin-43 Phosphorylation Modulation h-3a901ec3 | GJA1 | debated | 0.566 | 2026-05-16 | Open → |
| 44 | Temporal Decoupling via Circadian Clock Reset h-019ad538 | CLOCK | debated | 0.543 | 2026-05-16 | Open → |
| 45 | Glymphatic System-Enhanced Antibody Clearance Reversal h-62e56eb9 | AQP4 | debated | 0.537 | 2026-05-13 | Open → |
| 46 | Cryptic Exon Silencing Restoration h-4fabd9ce | TARDBP | debated | 0.531 | 2026-05-13 | Open → |
| 47 | Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioenergetics h-5ff6c5ca | SLC16A2 | debated | 0.529 | 2026-05-13 | Open → |
| 48 | Piezoelectric Nanochannel BBB Disruption h-7a8d7379 | CLDN5, OCLN | debated | 0.519 | 2026-05-16 | Open → |